HEALTH● LOW2h ago · Oct 2, 2026, 7:40 PM
Biogen phase 2 litifilimab data boosts lupus candidate
Seeking Alpha Tech · global
New data from Biogen's phase 2 trial for litifilimab suggests it is a promising candidate for treating lupus. This development could advance treatment options for the disease.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH52m agoThe FDA says cyclospora was found on a Mexican farm linked to a lettuce outbreakClarínHEALTH55m agoFDA extends review for Novo Nordisk's denecimig for hemophilia ASeeking Alpha TechHEALTH1h agoPatient died by suicide after insurance delayed medication: reportThe Independent WorldHEALTH2h agoEli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphomaSeeking Alpha Tech